SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-017435
Filing Date
2022-07-20
Accepted
2022-07-20 16:02:49
Documents
15
Period of Report
2022-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cenb20220719_8k.htm   iXBRL 8-K 26665
2 EXHIBIT 10.1 ex_396997.htm EX-10.1 19270
3 EXHIBIT 10.2 ex_396998.htm EX-10.2 16489
  Complete submission text file 0001437749-22-017435.txt   194001

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cenb-20220714.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20220714_def.xml EX-101.DEF 10806
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20220714_lab.xml EX-101.LAB 14416
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20220714_pre.xml EX-101.PRE 10852
9 EXTRACTED XBRL INSTANCE DOCUMENT cenb20220719_8k_htm.xml XML 2376
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55557 | Film No.: 221094265
SIC: 2834 Pharmaceutical Preparations